Robert V. Baumgartner - Aug 23, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 23, 2021
Transactions value $
-$1,592,623
Form type
4
Date filed
8/25/2021, 04:42 PM
Next filing
Nov 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $350K +4K +41.61% $87.39 13.6K Aug 23, 2021 Direct
transaction TECH Common Stock Sale -$144K -299 -2.2% $481.77 13.3K Aug 23, 2021 Direct F1
transaction TECH Common Stock Sale -$291K -601 -4.51% $483.60 12.7K Aug 23, 2021 Direct F2
transaction TECH Common Stock Sale -$291K -600 -4.72% $485.03 12.1K Aug 23, 2021 Direct F3
transaction TECH Common Stock Sale -$778K -1.6K -13.21% $486.25 10.5K Aug 23, 2021 Direct F4
transaction TECH Common Stock Sale -$390K -800 -7.61% $487.10 9.71K Aug 23, 2021 Direct F5
transaction TECH Common Stock Sale -$48.8K -100 -1.03% $487.88 9.61K Aug 23, 2021 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (right to buy) Options Exercise $0 -4K -100% $0.00* 0 Aug 23, 2021 Common Stock 4K $87.39 Direct
holding TECH Stock Options (right to buy) 4K Aug 23, 2021 Common Stock 4K $91.78 Direct
holding TECH Stock Options (right to buy) 4.26K Aug 23, 2021 Common Stock 4.26K $87.34 Direct
holding TECH Stock Options (right to buy) 3.99K Aug 23, 2021 Common Stock 3.99K $101.19 Direct
holding TECH Stock Options (right to buy) 3.13K Aug 23, 2021 Common Stock 3.13K $125.05 Direct
holding TECH Stock Options (right to buy) 1.9K Aug 23, 2021 Common Stock 1.9K $179.84 Direct
holding TECH Stock Options (right to buy) 2.01K Aug 23, 2021 Common Stock 2.01K $201.64 Direct
holding TECH Stock Options (right to buy) 1.51K Aug 23, 2021 Common Stock 1.51K $255.69 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $481.41 to $482.40, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $483.01 to $483.86, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $484.52 to $485.51, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.59 to $486.51, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $486.84 to $487.52, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $487.87 to $487.89, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The option vests on the earlier of the one year anniversary of the grant date (10/29/20) or the date of Bio-Techne's 2021 annual meeting of shareholders.